Other metabolites that have been identified to mediate beneficial effects and ameliorate obesity-associated metabolic dysfunction include tryptophan-based compounds which signal via the aryl hydrocarbon receptor63 and secondary bile acids that can function through the farnesoid X receptor (FXR)64,65. The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.